Georgia Health Sciences University. "A New And Powerful Class Of Antioxidants Could One Day Be A Potent Treatment For Parkinson's Disease." Medical News Today. MediLexicon, Intl., 25 Jul. 2012. Web.
Acting on the target NRF2 could be also very interesting in the FA
Wednesday, July 25, 2012
Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich's Ataxia.
Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich's Ataxia. Dey R, Kemp K, Gray E, Rice C, Scolding N, Wilkins A.; Cerebellum. 2012 Jul 24
Keywords: Friedreich's ataxia (FRDA), Oxidative damage, oxidative stress, frataxin deficiency, bone marrow-derived mesenchymal stem cells (MSCs), superoxide dismutase (1 and 2) enzymes, conditioned medium from human MSCs, nitric oxide-induced oxidative stress, PI(3) kinase/Akt.
Keywords: Friedreich's ataxia (FRDA), Oxidative damage, oxidative stress, frataxin deficiency, bone marrow-derived mesenchymal stem cells (MSCs), superoxide dismutase (1 and 2) enzymes, conditioned medium from human MSCs, nitric oxide-induced oxidative stress, PI(3) kinase/Akt.
Genetic testing in neurology
Genetic testing in neurology. Victoria Harrison, Andrea H. Nemeth; Medicine
Volume 40, Issue 8, August 2012, Pages 463–467. DOI: http://dx.doi.org/10.1016/j.mpmed.2012.05.009
Keywords: carrier testing, confidentiality, consent, diagnostic testing, genetic testing, neurogenetics, neurology, presymptomatic testing.
Keywords: carrier testing, confidentiality, consent, diagnostic testing, genetic testing, neurogenetics, neurology, presymptomatic testing.
Subscribe to:
Posts (Atom)
